Growing Patient Base Worldwide Fosters Expansion of Global Micro-Invasive Glaucoma Surgery (MIGS) Devices


Published Date : Jun 12, 2017

ALBANY, New York, June 12, 2017- MarketResearchReports.biz has announced the addition of a report titled, “Global Micro-Invasive Glaucoma Surgery (MIGS) Devices Market (By Target, By Surgery, By End User, By Region, By Country): Opportunities and Forecast (2017-2022) - By Target (Trabecular Meshwork, Suprachoroidal Space), By Surgery (Glaucoma - Cataract, Standalone), By End User (HOPD, ASCs), By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, U.K., Germany, France, Japan, South Korea, Australia, Brazil, South Africa)” to its offering. The report analyzes the key trends, growth drivers, and challenges prevailing in the global market for micro-invasive glaucoma surgery devices.

The report covers an evaluation of the value chain, apart from a detailed assessment of the leading market players. Various analytic tools have been utilized to conduct the study, which consists of secondary and primary research sources. The different leading segments of the global market for micro-invasive glaucoma surgery devices by region, end user, target, surgery, and country have been revealed. Growth potential held by various regions is also discussed in the report, apart from comprehensive diagrams, charts, and figures.

Also known as MIGS devices, micro-invasive glaucoma surgery devices are extensively used in glaucoma surgeries that aim at lowering eye pressure to reduce or prevent damage to the optic nerve. These surgeries primarily use tiny incisions and microscopic sized equipment. The rapidly expanding patient base in developing and developed countries, growing healthcare expenditures, and high incidence of glaucoma are driving the global market for micro-invasive glaucoma surgery devices.

For Sample Copy, click here: http://www.marketresearchreports.biz/sample/sample/1107693

By target, the global market for micro-invasive glaucoma surgery devices has been segmented into suprachoroidal space and trabecular meshwork. Of these, the latter held the largest share in the global market for micro-invasive glaucoma surgery devices. In terms of type of surgery, standalone and cataract are the two major categories. The standalone segment is expected to lead the overall market in terms of revenue. The global market for micro-invasive glaucoma surgery devices has been segmented into hospital outpatient departments (HOPDs) and ambulatory surgical centers (ASCs), of which the former segment has registered higher growth.

By region, the global market for micro-invasive glaucoma surgery devices has been segmented into Europe, North America, Asia Pacific, and the Rest of the World (RoW). Asia Pacific is prognosticated to command the greater share in the global market for micro-invasive glaucoma surgery devices. By country, France, Canada, South Korea, South Africa, the U.S., Japan, Germany, Brazil, the U.K., and Australia are the key segments of the global market for micro-invasive glaucoma surgery devices. 

The leading market players have been looking forward to join hands with other market participants, apart from investing in the development of novel devices. Mergers and acquisitions are also being established. Ivantis, Alcon, Santen Pharmaceuticals, Allergan, and Glaukos are some key companies operating in the global market for micro-invasive glaucoma surgery devices.

To order report Call Toll Free: 866-997-4948 or send an email on sales@marketresearchreports.biz